Trial · NCT03769298
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
NCT03769298, Phase 2, Phase 3, Recruiting, University of Wisconsin, Madison
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients. Trials, record NCT03769298. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03769298
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
- NCT number
- NCT03769298
- Status
- Recruiting
- Phases
- Phase 2, Phase 3
- Enrollment
- 20 participants, estimated
- Lead sponsor
- University of Wisconsin, Madison
- Conditions
- Kidney Pancreas Transplantation
- Interventions
- Envarsus XR
- First posted
- 2018-12-07
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in patient and physician-assessed degree of tremors based on Fahn-Tolosa-Marin Tremor Rating Scale | Over 6 months | FTM-TRS will be used as a tool for essential tremor scoring. (0: no tremor, 1: barely perceptible tremor, 2: \< 2 cm, 3: 2-4 cm, and 4: \> 4 cm). |
| Primary | Change in patient and physician-assessed degree of tremors based on Quality of Life in Essential Tremor (QUEST) Questionnaire | Over 6 months | QUEST Questionnaire, a scoring tool will be used to measure the quality of life among patients with Essential Tremor. It consists of 30 items which are rated on a five-point scale (score 0-4), corresponding to the frequency (never, rarely, sometimes, frequently, always) with which tremor was perceived to affect a function or to be associated with various feelings and attitudes. A few items (e.g. 'I had to quit my job because of tremor') could only be answered at the extremes (yes/no; true/false), and these were scored either 0 or 4. |
| Primary | Scores on Quality of Life in Essential Tremor Questionnaires | Over 6 months | Use QUEST (Quality of Life in Essential Tremor Questionnaire) scoring tool |
| Primary | Scores on Modified Transplant Symptom Occurrence and Symptom Distress Scale (MTSOSD) Questionnaire | Over 6 months | MTSOSD Questionnaire scores will be used to assess the presence and distress of side effects associated with the use of immunosuppressive drugs after transplantation. |
| Secondary | Renal function by eGFR (estimated Glomerular Filtration Rate) | Over 6 months | Change between baseline and post-conversion as measured by eGFR |
| Secondary | Renal function by serum creatinine | Over 6 months | Change between baseline and post-conversion as measured by serum creatinine |
| Secondary | Comparable or improved glycemic control as measured by mixed meal tolerance test | Over 6 months | Change between baseline and post-conversion |
| Secondary | Comparable or improved glycemic control as measured by HbA1c | Over 6 months | Change between baseline and post-conversion |
| Secondary | Tacrolimus doses and levels | Over 6 months | Change between baseline and post-conversion |
| Secondary | Mycophenolate doses and levels | Over 6 months | Change between baseline and post-conversion |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03769298
GET https://conductscience.org/api/trials/v1/NCT03769298/registered